|
Volumn 21, Issue 11, 2011, Pages 3373-3376
|
Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents
|
Author keywords
(8R,9S) 8,9 Dihydro 6,9 epoxy 8,9 anhydropseudoerythromycin A (EM900); 14 Membered non antibiotic macrolide; Anti inflammatory agent; Diffuse panbronchiolitis; Immunomodulatory agent
|
Indexed keywords
4'',13 O DIACETYL DIACETYL 8,9 DIHYDRO 6,9 EPOXY 8,9 ANHYDROPSEUDOERYTHROMYCIN A;
8,9 DIHYDRO 6,9 EPOXY 8,9 ANHYDROPSEUDOERYTHROMYCIN A;
ACID;
ANTIINFLAMMATORY AGENT;
ERYTHROMYCIN;
IMMUNOMODULATING AGENT;
MACROLIDE;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
CELL DIFFERENTIATION;
CYTOTOXICITY;
DRUG DESIGN;
DRUG EFFICACY;
DRUG STABILITY;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
MACROPHAGE;
MONOCYTE;
NONHUMAN;
ANTI-INFLAMMATORY AGENTS;
CELL DIFFERENTIATION;
CELLS, CULTURED;
DRUG DESIGN;
ERYTHROMYCIN;
HUMANS;
IMMUNOLOGIC FACTORS;
IMMUNOMODULATION;
MACROLIDES;
MACROPHAGES;
MICROBIAL SENSITIVITY TESTS;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
BACTERIA (MICROORGANISMS);
|
EID: 79956084563
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2011.04.004 Document Type: Article |
Times cited : (50)
|
References (21)
|